RealFeedApp Company cannot guarantee safety of copycat obesity drug
Apothecary Pharma voluntarily recalled 22 lots of compounded tirzepatide due to an inability to guarantee the medication's safety. The move supports claims that FDA-approved versions from Eli Lilly and Novo Nordisk offer superior quality and safety.
- Field
- drugs and trials
- What they did
- Pharmacy company Apothecary Pharma has issued a voluntary recall of 22 batches of its compounded tirzepatide because it could not guarantee the medication's safety.
- Why it matters
- This recall helps Eli Lilly and Novo Nordisk claim that their FDA-approved obesity medications are safer and more effective than the knockoff versions sold in pharmacies.
#tirzepatide#glp-1#pharmacy recall#fda#compounding
